EIPICO Says EIPICO 3 Facility Gets Final Operating License From Egyptian Drug Authority

About this update from Egyptian International Pharmaceutical Industries Co.

EGYPTIAN INTERNATIONAL PHARMACEUTICAL INDUSTRIES COMPANY EGX:PHAR:EIPICO 3 FACILITY GETS EGYPTIAN DRUG AUTHORITY (EDA) APPROVAL AND INTRODUCES ITS FIRST BIOLOGICAL PRODUCT "ADALIMAB"EDA APPROVAL PREPARES GROUND FOR STARTING OPERATIONS IN Q1 OF 2026RECEIVES FORMAL REQUEST AND PURCHASE ORDER TO SUPPLY ADALIMAB TO NAMIBIA

View stock analysis, news, and events for Egyptian International Pharmaceutical Industries Co.